In the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the previous day. This move outpaced the S&P 500's daily loss of 1.57%. Elsewhere, the Dow saw a downswing of ...

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.

"Global Virus-Like Particle Vaccine Market- (By Application Type (Infectious Diseases, Cancer Immunotherapy, Others), By Stage (Pre-clinical Research Stage, Approved Vaccines), By Distribution Channel ...

NEW YORK, NY / ACCESSWIRE / April 25, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class ...

If you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks can range from ...

The new private COVID-19 vaccine, manufactured by Novavax and delivered for the first time in the UK by an independent ...

Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company ...

Novavax ( NVAX 2.06%) was once a top-performing vaccine stock, soaring more than 2,000% in 2020 on optimism about its ...

In this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, ...

If you've wondered when your next COVID booster should be, national experts have the answer with a timeline for ongoing ...